We are live on ! Find out more
TXG icon

10x Genomics
TXG

254 hedge funds and large institutions have $3.91B invested in 10x Genomics in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 96 increasing their positions, 85 reducing their positions, and 92 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 85

2.91% more ownership

Funds ownership: 88.75% → 91.66% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

19% less funds holding

Funds holding: 314 → 254 (-60)

34% less call options, than puts

Call options by funds: $13.9M | Put options by funds: $21.1M

38% less capital invested

Capital invested by funds: $6.29B → $3.91B (-$2.38B)

61% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 92

Holders
254
Holders Change
-60
Holders Change %
-19.11%
% of All Funds
4.28%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
36
Increased
96
Reduced
85
Closed
92
Calls
$13.9M
Puts
$21.1M
Net Calls
-$7.23M
Net Calls Change
+$3.98M

Top Buyers

1
GIM
Generation Investment Management
United Kingdom
+$136M
2
SIM
SRS Investment Management
New York
+$132M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$107M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$53.1M
5
JP Morgan Chase
JP Morgan Chase
New York
+$48.1M

Top Sellers

1
BlackRock
BlackRock
New York
-$121M
2
Ameriprise
Ameriprise
Minnesota
-$81.9M
3
1WCM
12 West Capital Management
New York
-$65.8M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
-$55.1M
5
FAM
Fred Alger Management
New York
-$25M
Name Holding Trade Value Shares
Change 		Change in
Stake
TD Asset Management
76
TD Asset Management
Ontario, Canada
$2.63M -$228K -4,385 -7%
Ameriprise
77
Ameriprise
Minnesota
$2.6M -$81.9M -1,578,382 -96%
State of New Jersey Common Pension Fund D
78
State of New Jersey Common Pension Fund D
New Jersey
$2.55M +$338K +6,507 +13%
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
$2.34M +$244K +4,708 +10%
RJA
80
Raymond James & Associates
Florida
$2.3M -$114K -2,204 -4%
SG Americas Securities
81
SG Americas Securities
New York
$2.27M +$2.44M +47,047 +1,470%
Ohio Public Employees Retirement System (OPERS)
82
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.05M +$69.8K +1,346 +3%
Ensign Peak Advisors
83
Ensign Peak Advisors
Utah
$1.99M +$339K +6,535 +17%
Citigroup
84
Citigroup
New York
$1.92M -$1.3M -25,065 -37%
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.91M +$477K +9,194 +29%
CCM
86
Cinctive Capital Management
New York
$1.9M +$2.18M +42,055 New
RC
87
Renaissance Capital
Connecticut
$1.86M +$755K +14,546 +55%
NSAM
88
North Star Asset Management
Wisconsin
$1.81M -$17.2K -331 -0.8%
Treasurer of the State of North Carolina
89
Treasurer of the State of North Carolina
North Carolina
$1.74M +$380K +7,323 +24%
NEI
90
Northwest & Ethical Investments
Ontario, Canada
$1.74M +$516K +9,937 +35%
AllianceBernstein
91
AllianceBernstein
Tennessee
$1.66M +$34.4K +664 +2%
VOYA Investment Management
92
VOYA Investment Management
Georgia
$1.62M -$275K -5,298 -13%
Dimensional Fund Advisors
93
Dimensional Fund Advisors
Texas
$1.51M -$2.3M -44,392 -57%
ETCM
94
Evolutionary Tree Capital Management
Virginia
$1.5M -$1.09M -20,959 -39%
JRP
95
Jasper Ridge Partners
California
$1.46M +$178K +3,435 +12%
Jane Street
96
Jane Street
New York
$1.4M +$1.61M +30,986 New
Balyasny Asset Management
97
Balyasny Asset Management
Illinois
$1.36M +$1.56M +30,146 New
SEI Investments
98
SEI Investments
Pennsylvania
$1.32M +$82K +1,581 +5%
UIM
99
USS Investment Management
United Kingdom
$1.22M -$40.1K -772 -3%
Amundi
100
Amundi
France
$1.16M -$6.52M -125,694 -82%
2 3
4
5 6

TXG Hedge Fund Activity: Q2 2022 in Review

254 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q2 2022, worth a combined $3.91B — down 38% from $6.29B a quarter earlier.

Sellers outnumbered buyers: 92 funds closed out of TXG and 36 opened new positions — a net loss of 56 holders — while 85 trimmed existing stakes and 96 added.

The largest buyer was Generation Investment Management, opening a new position worth an estimated $136M. The largest seller was BlackRock, cutting an estimated $121M.

  • 254 institutional investors held 10x Genomics (TXG) as of Q2 2022, down from 314 in Q1 2022.
  • Funds reported $3.91B of 10x Genomics stock for Q2 2022, down 38% quarter-over-quarter.
  • 36 funds opened new 10x Genomics positions in Q2 2022 and 92 closed out, a net change of -56 holders.
  • The largest 10x Genomics buyer in Q2 2022 was Generation Investment Management, an estimated $136M added.
  • The largest 10x Genomics seller in Q2 2022 was BlackRock, an estimated $121M sold.

Based on aggregated 13F filings for Q2 2022.